| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655709 | Digestive and Liver Disease | 2017 | 7 Pages |
Abstract
Oral pulmonary vasoactive drugs are safe in cirrhotic patients with POPH. These treatments improved hemodynamic conditions allowing patients access to liver transplantation eligibility.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Ludivine Legros, Céline Chabanne, Christophe Camus, Maxime Fournet, Pauline Houssel-Debry, Marianne Latournerie, Caroline Jezequel, Michel Rayar, Karim Boudjema, Dominique Guyader, Edouard Bardou-Jacquet,